Sigh. I don't know whether you're being sarcastic. You're focusing on a country when we should be thinking about individuals. What I see is a population set that is currently excluded from survival due to the pricing of certain chemicals. This population set exists both in India and in our own backyard. There are 2 ways we can get access to a solution for that population set. One, allow generics to compete after a certain period. This tends to be natural, since reverse engineering a drug takes some time. During that time, big pharma can price the drug to maximize profit, after that, they have to compete better if they want to hold on to that profit.
No comments yet.